Cyber Vaccine Network Device Malware Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current malware detection methods rely heavily on digital signatures, which are ineffective against polymorphic, metamorphic malware and zero-day viruses, and require manual intervention for incident response, struggling to keep pace with the volume and variety of malware attacks.
Innovation Solution
The implementation of cyber-vaccination and cyber-antibody techniques, where a network device infected with malware generates a marker to identify and distribute to other devices, and monitoring packets to detect and block malicious communications, respectively, without the need for reverse engineering or extensive analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If digital signature-based malware detection is used, then known malware can be identified, but it is ineffective against polymorphic, metamorphic malware and zero-day viruses
Solution Approach 1:
The system performs preliminary action by proactively distributing cyber vaccines (markers) to uninfected network devices before they can be infected by malware. This preventive approach allows the system to block malware attacks before they succeed, rather than merely detecting them after infection occurs. The vaccine is prepared and deployed in advance based on analysis of infected devices.
Solution Approach 2:
The system creates and distributes copies of the cyber vaccine (marker) to multiple uninfected network devices. By replicating the protective marker across the network, the system enables widespread immunity without requiring each device to independently analyze malware samples. This copying approach efficiently scales protection across the entire network infrastructure.
2Measurement precision
If manual intervention is used for incident response, then detailed analysis can be performed, but it struggles to keep pace with the volume and variety of malware attacks
Solution Approach 1:
The system implements self-service by automatically analyzing infected network devices to generate cyber vaccines without requiring continuous manual intervention. Once the initial vaccine is created, the system autonomously distributes it across the network and continuously monitors for new infections. This automation maintains analytical precision while dramatically increasing response speed and scalability.
Solution Approach 2:
The system employs feedback mechanisms by continuously monitoring network devices for infection status and automatically updating vaccine distributions based on new threats detected. The automated response system learns from each infection event and adjusts its protective measures accordingly, maintaining both precision and speed through iterative improvement.
3Reliability
If cyber-vaccination technique is implemented, then real-time protection is provided, but it requires automatically distributing markers across the network
Solution Approach 1:
The cyber vaccine (marker) is designed with universality to provide multi-functional protection across diverse network devices and malware types. A single marker structure can protect against multiple threat vectors and be deployed on various device platforms, reducing the complexity of creating device-specific vaccines while maintaining comprehensive protection coverage.
Data Source
AI summary
Provided are systems, methods, and computer program products for a cyber-vaccination technique. In various implementations, the technique includes determine characteristics of a testing environment. A testing environment can be used to analyze malware programs. The technique can further include configuring a production network device with the characteristics, so that the production network device resembles the testing environment. The production network device is used for network operations, which excludes analyzing malware programs.